Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet's disease.
Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet's disease / Lopalco, G., Venerito, V., Cantarini, L., Emmi, G., Prisco, D., Iannone, F.. - In: INTERNAL AND EMERGENCY MEDICINE. - ISSN 1970-9366. - ELETTRONICO. - 14:(2019), pp. 719-722. [10.1007/s11739-018-1970-3]
Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet's disease
Emmi, Giacomo;
2019-01-01
Abstract
Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet's disease.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
